Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo

Detalles Bibliográficos
Autores principales: Deng, Wei, Xu, Yanfeng, Kong, Qi, Xue, Jing, Yu, Pin, Liu, Jiangning, Lv, Qi, Li, Fengdi, Wei, Qiang, Bao, Linlin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2020
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205908/
https://www.ncbi.nlm.nih.gov/pubmed/32385228
http://dx.doi.org/10.1038/s41392-020-0176-0
_version_ 1783530327627530240
author Deng, Wei
Xu, Yanfeng
Kong, Qi
Xue, Jing
Yu, Pin
Liu, Jiangning
Lv, Qi
Li, Fengdi
Wei, Qiang
Bao, Linlin
author_facet Deng, Wei
Xu, Yanfeng
Kong, Qi
Xue, Jing
Yu, Pin
Liu, Jiangning
Lv, Qi
Li, Fengdi
Wei, Qiang
Bao, Linlin
author_sort Deng, Wei
collection PubMed
description
format Online
Article
Text
id pubmed-7205908
institution National Center for Biotechnology Information
language English
publishDate 2020
publisher Nature Publishing Group UK
record_format MEDLINE/PubMed
spelling pubmed-72059082020-05-08 Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo Deng, Wei Xu, Yanfeng Kong, Qi Xue, Jing Yu, Pin Liu, Jiangning Lv, Qi Li, Fengdi Wei, Qiang Bao, Linlin Signal Transduct Target Ther Letter Nature Publishing Group UK 2020-05-08 /pmc/articles/PMC7205908/ /pubmed/32385228 http://dx.doi.org/10.1038/s41392-020-0176-0 Text en © The Author(s) 2020 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/.
spellingShingle Letter
Deng, Wei
Xu, Yanfeng
Kong, Qi
Xue, Jing
Yu, Pin
Liu, Jiangning
Lv, Qi
Li, Fengdi
Wei, Qiang
Bao, Linlin
Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo
title Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo
title_full Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo
title_fullStr Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo
title_full_unstemmed Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo
title_short Therapeutic efficacy of Pudilan Xiaoyan Oral Liquid (PDL) for COVID-19 in vitro and in vivo
title_sort therapeutic efficacy of pudilan xiaoyan oral liquid (pdl) for covid-19 in vitro and in vivo
topic Letter
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7205908/
https://www.ncbi.nlm.nih.gov/pubmed/32385228
http://dx.doi.org/10.1038/s41392-020-0176-0
work_keys_str_mv AT dengwei therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT xuyanfeng therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT kongqi therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT xuejing therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT yupin therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT liujiangning therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT lvqi therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT lifengdi therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT weiqiang therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo
AT baolinlin therapeuticefficacyofpudilanxiaoyanoralliquidpdlforcovid19invitroandinvivo

Ejemplares similares